Carol Ann Satler

President at Respira Therapeutics, Inc.

Health Technology

Consumer Services

Profile

Carol Ann Satler is currently the President, Director, and Chief Medical Officer at Respira Therapeutics, Inc. She was previously the President and Chief Executive Officer at Indigo Pharmaceuticals, Inc. She holds a doctorate degree from Case Western Reserve University and an undergraduate degree from Wesleyan University.

Carol Ann Satler active positions

Companies	Position	Start
Respira Therapeutics, Inc. Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM.	President	-

All active positions of Carol Ann Satler

Former positions of Carol Ann Satler

Companies	Position	End
Indigo Pharmaceuticals, Inc. Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY.	Chief Executive Officer	-

See the detail of Carol Ann Satler's experience

Training of Carol Ann Satler

Case Western Reserve University	Doctorate Degree
Wesleyan University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carol Ann Satler's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Indigo Pharmaceuticals, Inc. Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY.	Health Technology
Respira Therapeutics, Inc. Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM.	Health Technology